In cases with wild-type KRAS, BRAF and PIK3CA a number of cancer-associated genes representing potential drivers were identified (for example, STK11, GNAS, CHEK2 and RB1) (Supplementary Fig. 28). This evidence concerns the gene KRAS and cancer.